Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Anthem Blue Cross Blue Shield and Memorial Sloan Kettering Cancer Center have reached a deal that keeps the premiere cancer ...

The impasse comes as health insurance companies have faced heightened scrutiny following UnitedHealthcare CEO Brian ...

NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year ...

An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

The deal with Anthem marks the second high-profile payment battle between MSK and an insurance company this year. The cancer ...

Medical advancements make early-detected cancers more manageable and treatable, with immunotherapy and CAR T cell therapy ...

Oncologist David Chung is taking on Northwell Health's newly established role of director of clinical research at its cancer ...

Ann Graham of MIB Agents discussed some of the challenges adolescent and young adult patients deal with after cancer ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...